O

Oscotec Inc
KOSDAQ:039200

Watchlist Manager
Oscotec Inc
KOSDAQ:039200
Watchlist
Price: 55 000 KRW 5.16% Market Closed
Market Cap: ₩2.1T

Net Margin

-56.5%
Current
Improving
by 210.3%
vs 3-y average of -266.9%

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
-56.5%
=
Net Income
₩-13.1B
/
Revenue
₩23.2B

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
-56.5%
=
Net Income
₩-13.1B
/
Revenue
₩23.2B

Peer Comparison

Country Company Market Cap Net
Margin
KR
Oscotec Inc
KOSDAQ:039200
2.1T KRW
Loading...
US
Eli Lilly and Co
NYSE:LLY
972.2B USD
Loading...
US
Johnson & Johnson
NYSE:JNJ
547.5B USD
Loading...
CH
Roche Holding AG
SIX:ROG
277.1B CHF
Loading...
UK
AstraZeneca PLC
LSE:AZN
209.4B GBP
Loading...
CH
Novartis AG
SIX:NOVN
219B CHF
Loading...
US
Merck & Co Inc
NYSE:MRK
272.1B USD
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.7T DKK
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
US
Pfizer Inc
NYSE:PFE
148.3B USD
Loading...
FR
Sanofi SA
PAR:SAN
93.8B EUR
Loading...

Market Distribution

Lower than 91% of companies in Korea
Percentile
9th
Based on 2 632 companies
9th percentile
-56.5%
Low
-168 471.3% — -2.9%
Typical Range
-2.9% — 5.8%
High
5.8% — 21 012.5%
Distribution Statistics
Korea
Min -168 471.3%
30th Percentile -2.9%
Median 1.9%
70th Percentile 5.8%
Max 21 012.5%

Oscotec Inc
Glance View

Market Cap
2.1T KRW
Industry
Pharmaceuticals

Oscotec, Inc. engages in the development, manufacture and sale of pharmaceutical products. The company is headquartered in Seongnam, Gyeonggi-Do. The company went IPO on 2007-01-17. The firm operates its business through three divisions: new medicines division, functional material products division and dental bone graft division. Its new medicines division provides osteoporosis drugs, arthritis drugs and periodontal disease drugs. Its functional material products division provides functional materials and food used for promoting bone growth and periodontal health. Its dental bone graft division provides bone graft materials, membranes and centrifuges. The firm distributes its products within domestic market and to overseas markets.

Intrinsic Value
102 278.58 KRW
Undervaluation 46%
Intrinsic Value
Price
O
What is Net Margin?
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
How is Net Margin calculated?

Net Margin is calculated by dividing the Net Income by the Revenue.

Net Margin
-56.5%
=
Net Income
₩-13.1B
/
Revenue
₩23.2B
What is Oscotec Inc's current Net Margin?

The current Net Margin for Oscotec Inc is -56.5%, which is above its 3-year median of -266.9%.

How has Net Margin changed over time?

Over the last 3 years, Oscotec Inc’s Net Margin has increased from -520.1% to -56.5%. During this period, it reached a low of -569.7% on Jun 30, 2024 and a high of 9.8% on Jun 30, 2025.

Back to Top